These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34303952)

  • 1. Performance on a modified signal detection task of attention is impaired in male and female rats following developmental exposure to the synthetic progestin, 17α-hydroxyprogesterone caproate.
    Lolier M; Miller RO; Wood RI; Wagner CK
    Horm Behav; 2021 Sep; 135():105039. PubMed ID: 34303952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental exposure to the synthetic progestin, 17α-hydroxyprogesterone caproate, disrupts the mesocortical serotonin pathway and alters impulsive decision-making in rats.
    Fahrenkopf A; Li G; Wood RI; Wagner CK
    Dev Neurobiol; 2021 Sep; 81(6):763-773. PubMed ID: 34318625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental exposure to 17-α-hydroxyprogesterone caproate disrupts decision-making in adult female rats: A potential role for a dopaminergic mechanism.
    Graney PL; Chen MY; Wood RI; Wagner CK
    Horm Behav; 2024 Jul; 163():105550. PubMed ID: 38669977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental exposure to 17α-hydroxyprogesterone caproate impairs adult delayed reinforcement and reversal learning in male and female rats.
    Serpa RO; Wagner CK; Wood RI
    J Neuroendocrinol; 2020 Jun; 32(6):e12862. PubMed ID: 32485009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in dopamine innervation and microglia are altered by synthetic progestin in neonatal medial prefrontal cortex.
    Lolier M; Wagner CK
    J Neuroendocrinol; 2021 Mar; 33(3):e12962. PubMed ID: 33719165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental 17-OHPC exposure disrupts behavior regulated by the mesocorticolimbic dopaminergic system in rats.
    Graney PL; Chen MY; Wood RI; Wagner CK
    Pharmacol Biochem Behav; 2024 Oct; 245():173886. PubMed ID: 39368616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
    Saccone G; Khalifeh A; Elimian A; Bahrami E; Chaman-Ara K; Bahrami MA; Berghella V
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of Developmental 17-OHPC Exposure on the Mesocorticolimbic Serotonergic and Dopaminergic Pathways and Adolescent Mood-Related Behavior in Rats.
    Graney PL; Sarno EL; Miller JE; Wagner CK
    Dev Psychobiol; 2024 Sep; 66(6):e22536. PubMed ID: 39164823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug.
    Elfarra JT; Cottrell JN; Cornelius DC; Cunningham MW; Faulkner JL; Ibrahim T; Lamarca B; Amaral LM
    Pregnancy Hypertens; 2020 Jan; 19():226-232. PubMed ID: 31806502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of formulation and route of administration on the distribution of 17-hydroxyprogesterone caproate in rats.
    Shaik IH; Chaphekar N; Vasudevan V; Alshabi A; Bastian JR; Zhao W; Caritis S; Venkataramanan R
    Xenobiotica; 2023 Mar; 53(3):193-200. PubMed ID: 37039113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.
    Kumar D; Moore RM; Mercer BM; Mansour JM; Mesiano S; Schatz F; Lockwood CJ; Moore JJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):695.e1-695.e14. PubMed ID: 29031893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
    Mulder EJ; Versteegh EM; Bloemenkamp KW; Lim AC; Mol BW; Bekedam DJ; Kwee A; Bruinse HW; Christiaens GC
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):329-34. PubMed ID: 23592400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.
    Caritis SN; Sharma S; Venkataramanan R; Rouse DJ; Peaceman AM; Sciscione A; Spong CY; Varner MW; Malone FD; Iams JD; Mercer BM; Thorp JM; Sorokin Y; Carpenter M; Lo J; Ramin S; Harper M;
    Am J Obstet Gynecol; 2011 Jul; 205(1):40.e1-8. PubMed ID: 21620357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to the Synthetic Progestin, 17α-Hydroxyprogesterone Caproate During Development Impairs Cognitive Flexibility in Adulthood.
    Willing J; Wagner CK
    Endocrinology; 2016 Jan; 157(1):77-82. PubMed ID: 26556535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation.
    Sharma S; Caritis S; Hankins G; Miodovnik M; Hebert MF; Mattison D; Venkataramanan R
    Br J Clin Pharmacol; 2016 Oct; 82(4):1084-93. PubMed ID: 27133963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention.
    Zhang S; Rascati KL
    Curr Med Res Opin; 2021 Sep; 37(9):1667-1675. PubMed ID: 34030550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.
    Feghali M; Venkataramanan R; Caritis S
    Semin Perinatol; 2014 Dec; 38(8):516-22. PubMed ID: 25256193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
    Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
    Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between 17-hydroxyprogesterone caproate use and postpartum hemorrhage.
    Miller ES; Sakowicz A; Roy A; Liu LY; Yee LM
    Am J Obstet Gynecol MFM; 2019 May; 1(2):144-147. PubMed ID: 32914089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation.
    Caritis SN; Sharma S; Venkataramanan R; Hankins GD; Miodovnik M; Hebert MF; Umans JG; Benedetti T; Mattison D; Zajicek A; Fischer D; Jackson A;
    Am J Obstet Gynecol; 2012 Nov; 207(5):398.e1-8. PubMed ID: 22967833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.